NYSE:APHA - Aphria Stock Price, News & Analysis

+0.01 (+0.16 %)
(As of 08/20/2019 04:00 PM ET)
Today's Range
Now: $6.25
50-Day Range
MA: $6.39
52-Week Range
Now: $6.25
Volume2.64 million shs
Average Volume5.57 million shs
Market Capitalization$1.57 billion
P/E RatioN/A
Dividend YieldN/A
Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc. is headquartered in Leamington, Canada.

Industry, Sector and Symbol

Industry N/A



Sales & Book Value

Annual Sales$179.29 million



Market Cap$1.57 billion
Next Earnings Date10/11/2019 (Estimated)
OptionableNot Optionable

Receive APHA News and Ratings via Email

Sign-up to receive the latest news and ratings for APHA and its competitors with MarketBeat's FREE daily newsletter.

Aphria (NYSE:APHA) Frequently Asked Questions

What is Aphria's stock symbol?

Aphria trades on the New York Stock Exchange (NYSE) under the ticker symbol "APHA."

How were Aphria's earnings last quarter?

Aphria Inc (NYSE:APHA) announced its quarterly earnings results on Thursday, August, 1st. The company reported $0.05 earnings per share for the quarter, topping analysts' consensus estimates of ($0.05) by $0.10. The business had revenue of $128.60 million for the quarter, compared to analysts' expectations of $99.26 million. The firm's revenue for the quarter was up 971.7% on a year-over-year basis. View Aphria's Earnings History.

When is Aphria's next earnings date?

Aphria is scheduled to release their next quarterly earnings announcement on Friday, October 11th 2019. View Earnings Estimates for Aphria.

What price target have analysts set for APHA?

7 brokers have issued twelve-month target prices for Aphria's stock. Their forecasts range from $7.00 to $22.75. On average, they expect Aphria's share price to reach $14.75 in the next twelve months. This suggests a possible upside of 136.0% from the stock's current price. View Analyst Price Targets for Aphria.

What is the consensus analysts' recommendation for Aphria?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aphria.

What are Wall Street analysts saying about Aphria stock?

Here are some recent quotes from research analysts about Aphria stock:
  • 1. According to Zacks Investment Research, "Aphria Inc. produces, supplies and sells medical cannabis primarily in Canada. The company offers sativa, indica and hybrid medical marijuana products, as well as cannabis oils. Aphria Inc. is headquartered in Leamington, Canada. " (8/7/2019)
  • 2. Clarus Securities analysts commented, "We had previously assumed a run-rate of ~$865MM by the end of CY2020; we are now in line with management’s target." (4/16/2019)

Has Aphria been receiving favorable news coverage?

News articles about APHA stock have trended positive this week, according to InfoTrie. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Aphria earned a coverage optimism score of 2.5 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the stock's share price in the near term. View News Stories for Aphria.

Who are some of Aphria's key competitors?

What other stocks do shareholders of Aphria own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Tilray (TLRY), HEXO (HEXO), KushCo (KSHB), Aurora Cannabis (ACB), NVIDIA (NVDA), Advanced Micro Devices (AMD) and OrganiGram (OGI).

Who are Aphria's key executives?

Aphria's management team includes the folowing people:
  • Mr. Carl A. Merton, Chief Financial Officer
  • Ms. Megan McCrae, Director of Marketing
  • Mr. Irwin D. Simon, Interim CEO & Chairman
  • Mr. Jakob Ripshtein, Pres
  • Mr. Gary Leong, Chief Science Officer (Age 54)

Who are Aphria's major shareholders?

Aphria's stock is owned by a number of of institutional and retail investors. Top institutional investors include ETF Managers Group LLC (2.78%), Vanguard Group Inc. (2.15%), Morgan Stanley (0.68%), TD Asset Management Inc. (0.27%), Bank of America Corp DE (0.20%) and Swiss National Bank (0.18%).

Which major investors are selling Aphria stock?

APHA stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Commerzbank Aktiengesellschaft FI, TD Asset Management Inc., Intercontinental Wealth Advisors LLC and Cetera Advisor Networks LLC.

Which major investors are buying Aphria stock?

APHA stock was acquired by a variety of institutional investors in the last quarter, including ETF Managers Group LLC, Jefferies Group LLC, Bank of America Corp DE, Renaissance Technologies LLC, Scotia Capital Inc., Vanguard Group Inc., Cubist Systematic Strategies LLC and Jane Street Group LLC.

How do I buy shares of Aphria?

Shares of APHA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aphria's stock price today?

One share of APHA stock can currently be purchased for approximately $6.25.

How big of a company is Aphria?

Aphria has a market capitalization of $1.57 billion and generates $179.29 million in revenue each year. Aphria employs 300 workers across the globe.View Additional Information About Aphria.

MarketBeat Community Rating for Aphria (NYSE APHA)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  88 (Vote Outperform)
Underperform Votes:  90 (Vote Underperform)
Total Votes:  178
MarketBeat's community ratings are surveys of what our community members think about Aphria and other stocks. Vote "Outperform" if you believe APHA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APHA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel